Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of gE/AS01B zoster vaccine in healthy older adults
2006-004863-69Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Zoster vaccine recombinant in herpes zoster (HZ) (2 arms), sponsored by GSK. Primary endpoint: Main objective comparison. Started Oct 2006; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2006-004863-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004863-69.